Nabriva Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NBRV and other ETFs, options, and stocks.

About NBRV

Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and commercialization of novel anti-infective agents to treat serious infections. Its product pipeline includes Lefamulin, CONTEPO, and BC-7013. 

CEO
Theodore R. Schroeder
CEOTheodore R. Schroeder
Employees
73
Employees73
Headquarters
Dublin, Dublin
HeadquartersDublin, Dublin
Founded
2005
Founded2005
Employees
73
Employees73

NBRV Key Statistics

Market cap
5.62M
Market cap5.62M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
239.66K
Average volume239.66K
High today
$2.16
High today$2.16
Low today
$2.04
Low today$2.04
Open price
$2.11
Open price$2.11
Volume
88.93K
Volume88.93K
52 Week high
$35.00
52 Week high$35.00
52 Week low
$2.04
52 Week low$2.04

NBRV Earnings

-$16.75
-$11.17
-$5.58
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8, After Hours
ActualExpected Nov 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.